BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2016
View Archived Issues
BioLineRx and Genentech to investigate atezolizumab plus BL-8040 in oncology indications
Read More
Idera finds unique mechanism behind third-generation antisense oligonucleotides
Read More
First clinical data reported for asthma candidate BI-1060469
Read More
AZD-8999 shows good bronchodilator profile in phase I trial in patients with COPD
Read More
Moerae Matrix presents phase I data for MMI-0100
Read More
Glenmark announces discovery of GBR-1372
Read More
Emmaus submits NDA for sickle cell disease treatment
Read More
DelMar Pharmaceuticals and Accurexa to develop combination chemotherapy for brain cancer
Read More
FDA expands EUA for Aptima Zika virus diagnostic assay to be used with urine samples
Read More
LentiGlobin enters phase III testing in patients with transfusion-dependent beta-thalassemia
Read More
FDA clears clinical testing of Carmeseal-MD in DMD
Read More
GTx's phase II study of enobarsarm achieves stage one milestone
Read More
Alnylam Pharmaceuticals provides interim phase I data for ALN-AS1 in acute intermittent porphyria
Read More
Celyad completes phase I trial of NKR-2 T-cell therapy
Read More
Data on long-term administration of rhGUS in mucopolysaccharidosis type VII reported
Read More
Stanford University and twoXAR enter HCC collaboration
Read More
RedHill Biopharma begins phase Ib/II study of Yeliva
Read More
Cytokinetics reaches milestone in skeletal muscle activator collaboration with Astellas
Read More
Oncoceutics provides update on phase I study of ONC-201
Read More
Screening study set to open for irofulven trial in prostate cancer
Read More
Axxam and Mercachem announce strategic alliance
Read More
HDAC/PI3K inhibitor from Curis granted orphan drug status in the U.S.
Read More
Bristol-Myers Squibb, Universite de Montreal patent novel PAR4 antagonists
Read More
NIH announces launch of ADNI3
Read More
University of Michigan discloses new bromodomain-containing protein 4 inhibitors
Read More
Nimbus Lakshmi presents novel TYK2 inhibitors
Read More
Lycera presents novel Rho-associated protein kinase 2 inhibitors
Read More
Curtana Pharmaceuticals describes new Oligo2 inhibitors
Read More